BD Completes Acquisition of TriPath Imaging
Expands Presence in Cancer Diagnostics Market
Advertisement
BD (Becton, Dickinson and Company) announced the completion of its acquisition of TriPath Imaging. The acquisition was finalized in accordance with terms originally disclosed in an announcement issued by BD on September 8, 2006.
According to the company, this strategic acquisition aligns innovative new technologies with BD's existing business strategies and is a natural complement to ongoing internal research programs in its BD Diagnostics and BD Biosciences segments. These oncology management tools are intended to span cancer screening, diagnosis, prognosis and therapy monitoring, especially for cancers affecting women's health, including breast, cervical and ovarian.